Assessing the Value of New Cancer Treatments and Innovations webinar

In this webinar, speakers discuss value assessment frameworks for cancer treatment, combination treatments, multi-indications, cell therapies and precision oncology. They reflect on public and patient involvement into health research; challenges and solutions, and representation at different stages of the research lifecycle. The webinar is of particular interest to healthcare policy makers, managers, care providers and researchers.

00:00 Prof Jan Sorensen, Director, Healthcare Outcomes Research Centre, RCSI School of Population Health: Introduction
01:57 Dr Ronan Glynn, Health Sector Lead, EY Ireland: Welcome
03:34 Dr Avril Kennan, CEO, Health Research Charities Ireland: What is value and how do we achieve it?
22:59 Dr Susan Spillane, Deputy Director of the HTA Directorate, Health Information and Quality Authority (HIQA), Ireland: HIQA’s role in assessment of cancer interventions
54:05 Prof George Crooks, CEO, Digital Health & Care Innovation Centre, Scotland: Aim 4 All – Access to innovative medicines for all
01:15:06 Panel discussion

The Future of Cancer in Ireland: Health Economic Perspectives webinar series is organised by the Healthcare Outcomes Research Centre, RCSI School of Population Health.

The webinar series is supported by Janssen, Novartis and EY.

Видео Assessing the Value of New Cancer Treatments and Innovations webinar канала RCSI